Abstract
Background: To study the association of Non Alcoholic Fatty Liver Disease in patients of Coronary Artery Disease. Subjects and Methods: 100 patients of established CAD admitted were included in the study. Patients were screened for NAFLD with USG. 2 groups were made: CAD with NAFLD & CAD without NAFLD and comorbidities were identified and evaluated for Risk Factors and Correlation was identified. Result: Majority of study subjects (79%) were males and 21% were females. Highest proportion of subjects (29%) were in 51-60 years of age and lowest (9%) in above 70 years of age. Chest pain was the commonest presenting symptom preceding breathlessness and sweating. In the fatty liver group, a high proportion of subjects had history of Type-II DM (31% vs 4%) and Hypertension (18% vs 11%) in comparison to normal liver group. The mean BMI of study participants in the present study was 29.5 kg/m2. In fatty liver group, higher proportion of subjects had fasting blood glucose levels > 126 (66.7%) than the non-fatty liver subjects (3.8%). higher proportion of subjects had total cholesterol levels higher than 200 (14.6%) than the non-fatty liver subjects (1.9%). In group with non-fatty liver, greater proportion of subjects had LDL levels higher than 100 (40.4%) than the fatty liver group (33.3%). it was found that 37.5% subjects had mild grade of NAFLD whereas 43.8% had moderate grade and 18.7% had severe grade of NAFLD. Conclusion: There is a significant relationship between NAFLD and an elevated CVD risk in those with or without Metabolic Syndrome.
The full text of this article is available as a PDF.
Download PDF- 1. Ahmed MH, Barakat S, Almobarak AO. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists? J Obesity. 2012;2012:483135. Available from: https://doi.org/10.1155/ 2012/483135.
- 2. Lerchbaum E, Pilz S, Grammer TB, Boehm BO, Stojakovic T, Obermayer-Pietsch B. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography. Nutr Metab Cardiovasc Dis. 2013;23(12):1231– 1238. Available from: https://doi.org/10.1016/j.numecd.2013. 02.004.
- 3. Zafar KS, Wafai NA, Haque SF. Correlation of non-alcoholic fatty liver disease in patients of coronary artery disease. Int J Res Med Sci. 2016;4(3):739–742. Available from: https: //dx.doi.org/10.18203/2320-6012.ijrms20160510.
- 4. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191(2):235–240. Available from: https://doi.org/10. 1016/j.atherosclerosis.2006.08.021.
- 5. Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J Hepatol. 2016;65(3):589–600. Available from: https://doi.org/10.1016/j.jhep.2016.05.013.
- 6. Wong VS, Wong GH, Yeung JL, Fung CK, Chan JL, Chang ZY. Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study. Hepatology. 2016;63(3):754–763. Available from: https://doi.org/10.1002/hep.28253.
- 7. Ma J, Hwang SJ, Pedley A, Massaro JM, Hoffmann U, Chung RT. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. J Hepatol. 2017;66(2):390– 397. Available from: https://doi.org/10.1016/j.jhep.2016.09. 022.
- 8. Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Association of non alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis. Sci Rep. 2016;6:33386.
- 9. Wild SH, Walker JJ, Morling JR, Mcallister DA, Colhoun HM, Farran B, et al. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission. Diabetes Care. 2018;41(2):341–347. Available from: https: //doi.org/10.2337/dc17-1590.
- 10. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–357. Available from: https://doi. org/10.1002/hep.29367.
- 11. Mullish BH, Forlano R, Manousou P, Mikhailidis DP. Non alcoholic fatty liver disease and cardiovascular risk: an update. Expert Rev Gastroenterol Hepatol. 2018;12(12):1175– 1182. Available from: https://doi.org/10.1080/17474124.2018. 1533117.
- 12. Wong CR, Lim JK. The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes. Clin Liver Dis (Hoboken). 2018;12(2):39–44. Available from: https://dx.doi.org/10.1002/cld.721.
- 13. Chan WK, Tan AB, Vethakkan SR, Tah PC, Vijayananthan A, Goh KL. Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic
- population. Clin Res Hepatol Gastroenterol. 2014;38(3):284– 91. Available from: https://doi.org/10.1016/j.clinre.2014.02. 009.
- 14. Montemezzo M, Alturki A, Stahlschmidt F, Olandoski M, Tafarel R, Precoma J, et al. Nonalcoholic Fatty Liver Disease and Coronary Artery Disease: Big Brothers in Patients with Acute Coronary Syndrome. Sci World J. 2020;2020:1–5. Available from: https://doi.org/10.1155/2020/8489238.
Looking up citing articles…